Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT03443024

Public ClinicalTrials.gov record NCT03443024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 7:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of lebrikizumab compared with placebo in participants with moderate-to-severe atopic dermatitis.

Study identification

NCT ID
NCT03443024
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
280 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 29, 2018
Primary completion
Feb 6, 2019
Completion
May 22, 2019
Last update posted
May 3, 2021

2018 – 2019

United States locations

U.S. sites
58
U.S. states
28
U.S. cities
54
Facility City State ZIP Site status
Clear Dermatology & Aesthetics Center Scottsdale Arizona 85255
Dermatology Trial Associates Bryant Arkansas 72022
Northwest Arkansas Clinical Trials Center Rogers Arkansas 72758
Center for Dermatology Clinical Research, Inc. Fremont California 94538
University of Southern California Los Angeles California 90033
Dermatology Research Associates Los Angeles California 90045
Stanford Medicine Outpatient Center-Medical Dermatology Clinic Redwood City California 94063
Center for Dermatology and Laser Surgery Sacramento California 95819
UCSD Dermatology San Diego California 92122
TCR Medical Corporation San Diego California 92123
Clinical Science Institute Santa Monica California 90404
George Washington Medical Faculty Associates Washington D.C. District of Columbia 20037
Total Vein and Skin Boynton Beach Florida 33437
Florida Academic Centers Research and Education, LLC Coral Gables Florida 33134
Olympian Clinical Research Largo Florida 33770
Tory Sullivan, MD PA North Miami Beach Florida 33162
International Clinical Research - US, LLC Sanford Florida 32771
Integrated Clinical Research, LLC West Palm Beach Florida 33406
Marietta Dermatology Clinical Research, Inc. Marietta Georgia 30060
Advanced Medical Research, PC Sandy Springs Georgia 30328
Dundee Dermatology West Dundee Illinois 60118
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
The Indiana Clinical Trials Center Plainfield Indiana 46168
Kansas City Dermatology, PA Overland Park Kansas 66215
Skin Sciences, PLLC Louisville Kentucky 40217
Meridian Clinical Research, LLC Baton Rouge Louisiana 70808
Dermatology and Skin Cancer Specialists, LLC Rockville Maryland 20850
ActivMed Practices & Research, Inc. Beverly Massachusetts 01915
Tufts Medical Center Boston Massachusetts 02111
Somerset Skin Centre Troy Michigan 48084
JDR Dermatology Research Las Vegas Nevada 89148
ActivMed Practices & Research, Inc. Portsmouth New Hampshire 03801
Academic Dermatology Associates Albuquerque New Mexico 87106
Schweiger Dermatology, PLLC New York New York 10022
Icahn School of Medicine New York New York 10029
Sadick Research Group, LLC. New York New York 10075
DermResearchCenter of New York, Inc. Stony Brook New York 11790
Piedmont Plastic Surgery and Dermatology Charlotte North Carolina 28277
Wake Research Associates, LLC Raleigh North Carolina 27612
Wilmington Dermatology Center Wilmington North Carolina 28405
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Lynn Health Science Institute Oklahoma City Oklahoma 73112
Oregon Medical Research Center Portland Oregon 97223
Clinical Partners, LLC Johnston Rhode Island 02919
Clinical Research Center of the Carolinas Charleston South Carolina 29407
Rivergate Dermatology Clinical Research Center Goodlettsville Tennessee 37072
International Clinical Research - Tennessee LLC Murfreesboro Tennessee 37130
Tennessee Clinical Research Center Nashville Tennessee 37215
Arlington Research Center, Inc. Arlington Texas 76011
Westlake Dermatology Clinical Research Center Austin Texas 78746
Bellaire Dermatology Associates Bellaire Texas 77401
Menter Dermatology Research Dallas Texas 75246
The University of Texas Health Houston Texas 77030
Progressive Clinical Research, PA San Antonio Texas 78213
Center for Clinical Studies, LTD. LLP Webster Texas 77598
Virginia Clinical Research, Inc. Norfolk Virginia 23502
Dermatology Associates of Seattle Seattle Washington 98101
Premier Clinical Research Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03443024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2021 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03443024 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →